The store will not work correctly when cookies are disabled.
8-Ethoxy-8-(3-methoxyphenyl)-5-methyl-8H-[1,2,4]oxadiazolo-[3,4-c][1,4]thiazin-3-one
ID: ALA3819168
PubChem CID: 127051508
Max Phase: Preclinical
Molecular Formula: C15H16N2O4S
Molecular Weight: 320.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC1(c2cccc(OC)c2)SC=C(C)n2c1noc2=O
Standard InChI: InChI=1S/C15H16N2O4S/c1-4-20-15(11-6-5-7-12(8-11)19-3)13-16-21-14(18)17(13)10(2)9-22-15/h5-9H,4H2,1-3H3
Standard InChI Key: VEZHXJRRLTWVEZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0825 2.3453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3007 -2.2271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2993 -2.2188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3320 -3.7267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6463 -4.4495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9295 -3.6727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8983 -2.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5839 -1.4502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9991 2.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1805 -1.3931 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.1538 -0.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3765 -3.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4449 -4.2641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 4 1 0
2 6 1 0
5 3 1 0
3 4 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 2 0
7 10 2 0
3 11 1 0
3 12 1 0
11 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 11 1 0
2 18 1 0
16 19 1 0
19 20 1 0
12 21 1 0
21 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.37 | Molecular Weight (Monoisotopic): 320.0831 | AlogP: 2.65 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.49 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.97 | CX LogD: 2.97 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.86 | Np Likeness Score: -0.63 |
References
1. Carosati E, Cosimelli B, Ioan P, Severi E, Katneni K, Chiu FC, Saponara S, Fusi F, Frosini M, Matucci R, Micucci M, Chiarini A, Spinelli D, Budriesi R.. (2016) Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism., 59 (7): [PMID:26962886] [10.1021/acs.jmedchem.6b00030] |